Patents by Inventor James R. Moore
James R. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240002162Abstract: In various aspects and embodiments the system described herein provides a novel robotic culling system employing a plurality of sorting and orienting robotic systems to cull a moving package stream. A wide variety of embodiments and uses may be employed implementing the apparatus and system utilizing a variety of structures without departing from the teachings of this specification.Type: ApplicationFiled: July 1, 2022Publication date: January 4, 2024Inventor: James R Moore, II
-
Patent number: 11204347Abstract: A test device for testing of an oxygen sensor uses a compressor to draw air from an external environment and deliver compressed air into a gas separation unit. A gas separation membrane is located in a passage of the gas separation unit such that compressed air from the compressor travels through the passage and passes through the gas separation membrane. The gas separation membrane separates at least one of nitrogen and oxygen from the compressed air to produce a calibration gas having a calibrated amount of oxygen that is different from an amount of oxygen in the air. The calibration gas coupling is configured to be fluidly connected to the oxygen sensor such that the calibration gas is deliverable from the calibration gas coupling to the oxygen sensor.Type: GrantFiled: March 18, 2019Date of Patent: December 21, 2021Inventors: Ferrel D. Moore, James R. Moore
-
Publication number: 20200300826Abstract: A test device for testing of an oxygen sensor uses a compressor to draw air from an external environment and deliver compressed air into a gas separation unit. A gas separation membrane is located in a passage of the gas separation unit such that compressed air from the compressor travels through the passage and passes through the gas separation membrane. The gas separation membrane separates at least one of nitrogen and oxygen from the compressed air to produce a calibration gas having a calibrated amount of oxygen that is different from an amount of oxygen in the air. The calibration gas coupling is configured to be fluidly connected to the oxygen sensor such that the calibration gas is deliverable from the calibration gas coupling to the oxygen sensor.Type: ApplicationFiled: March 18, 2019Publication date: September 24, 2020Inventors: Ferrel D. Moore, James R. Moore
-
Patent number: 9790891Abstract: A Stirling engine power generation system comprises a first gas fired Stirling engine driving a scroll compressor to provide heat to a second Stirling engine powered generator. The second Stirling engine is partially submersed in a heat transfer medium that is heated by heat transfer fluid compressed by the Stirling scroll compressor and excess heat from gas firing. The invention further comprises a cam drive system with spherical cam followers, and multiple electrical generators.Type: GrantFiled: June 30, 2011Date of Patent: October 17, 2017Inventor: James R. Moore, II
-
Publication number: 20150313883Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: July 10, 2015Publication date: November 5, 2015Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Patent number: 9107915Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.Type: GrantFiled: June 5, 2014Date of Patent: August 18, 2015Assignee: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20140288132Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: June 5, 2014Publication date: September 25, 2014Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Patent number: 8833381Abstract: A decorating tip cleaning apparatus includes a first frame member having opposed front and rear edges and a second frame member having opposed front and rear edges. The rear edges of the frame members are pivotally coupled together such that the first and the second frame members are movable between a closed configuration at which the front edges, respectively, are generally adjacent one another and an open configuration at which the front edges, respectively, are separated from one another. The first and second frame members include a mesh material extending between respective front and rear edges. The mesh material of the first frame member defines a plurality of apertures spaced apart from one another, each aperture being configured to receive a decorating tip partially therethrough. Each aperture is configured to receive only a portion of a respective decorating tip.Type: GrantFiled: May 31, 2012Date of Patent: September 16, 2014Inventor: James R. Moore
-
Patent number: 8778978Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: GrantFiled: October 3, 2013Date of Patent: July 15, 2014Assignee: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20140039014Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: October 3, 2013Publication date: February 6, 2014Applicant: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20130318736Abstract: A decorating tip cleaning apparatus includes a first frame member having opposed front and rear edges and a second frame member having opposed front and rear edges. The rear edges of the frame members are pivotally coupled together such that the first and the second frame members are movable between a closed configuration at which the front edges, respectively, are generally adjacent one another and an open configuration at which the front edges, respectively, are separated from one another. The first and second frame members include a mesh material extending between respective front and rear edges. The mesh material of the first frame member defines a plurality of apertures spaced apart from one another, each aperture being configured to receive a decorating tip partially therethrough. Each aperture is configured to receive only a portion of a respective decorating tip.Type: ApplicationFiled: May 31, 2012Publication date: December 5, 2013Inventor: James R. Moore
-
Patent number: 8580826Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: GrantFiled: October 26, 2011Date of Patent: November 12, 2013Assignee: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20120041033Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: October 26, 2011Publication date: February 16, 2012Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20120000194Abstract: A Stirling engine power generation system comprises a first gas fired Stirling engine driving a scroll compressor to provide heat to a second Stirling engine powered generator. The second Stirling engine is partially submersed in a heat transfer medium that is heated by heat transfer fluid compressed by the Stirling scroll compressor and excess heat from gas firing. The invention further comprises a cam drive system with spherical cam followers, and multiple electrical generators.Type: ApplicationFiled: June 30, 2011Publication date: January 5, 2012Inventor: James R. Moore, II
-
Patent number: 8053451Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: GrantFiled: November 4, 2008Date of Patent: November 8, 2011Assignee: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Patent number: 7865380Abstract: System and process for managing an IT infrastructure which collects transaction information on a component basis. The transaction data is used to evaluate the contribution of each component of the system as well as the business value of the service, and for the infrastructure as a whole. The usage data is prepared as reports and used in an IT management workflow model to make decisions about such things as the timing of system upgrades, strategic architectural decisions, timing of sunsetting of service components, both hardware and software, and the return-on-investment (ROI) valuation of IT investments. Component values may be assessed on either a volume (number of transactions) basis, or on the discrete dollar value of the transactions supported by the component.Type: GrantFiled: November 8, 2001Date of Patent: January 4, 2011Assignee: International Business Machines CorporationInventors: L. Mark Ernest, Christopher Finden-Browne, James R. Moore
-
Publication number: 20090062321Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: November 4, 2008Publication date: March 5, 2009Applicant: TARGACEPT, INC.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Patent number: 7459469Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine) or to another pharmaceutically acceptable salt form.Type: GrantFiled: November 9, 2005Date of Patent: December 2, 2008Assignee: Targacept, Inc.Inventors: Julio A. Munoz, John Genus, James R. Moore
-
Publication number: 20080249142Abstract: Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof compositions that are hydroxybenzoate salts of E-metanicotine-type compounds. The formation of hydroxybenzoate salts of the E-metanicotine compounds is also useful in purifying the E-metanicotine compounds, as the hydroxybenzoate salts tend to crystallize out, leaving impurities such as Z-metanicotine compounds, and compounds where the double bond has migrated, in solution. If desired, the hydroxybenzoate salts can be converted to either the free base (the E-metanicotine compound) or to another pharmaceutically acceptable salt form.Type: ApplicationFiled: June 19, 2008Publication date: October 9, 2008Applicant: Targacept, Inc.Inventors: Gary Maurice Dull, Julio A. Munoz, John Genus, James R. Moore
-
Patent number: D652271Type: GrantFiled: November 1, 2010Date of Patent: January 17, 2012Assignee: Molenaar, LLCInventors: James R. Moore, Ronald E. Markfelder